This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Teva Gyógyszergyár Zártkör{acute Over ())}{Acute Over (})}Úen M{acute Over ())}{Acute Over (})}úköd{acute Over ())}{Acute Over (})}Ó Részvénytársaság. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Zsolt Tomas Suto: Innovator in Echinocandin Purification Processes
Introduction
Zsolt Tomas Suto is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the purification processes of echinocandin-type compounds. His work has implications for the development of antifungal medications, which are crucial in treating various infections.
Latest Patents
Zsolt Tomas Suto holds a patent for "Purification processes for echinocandin-type compounds." This invention provides a method for preparing and purifying compounds such as pneumocandin Bo, WF 11899A, and echinocandin B. These compounds are fermentation products that serve as precursors for semi-synthetic antifungal products, including Caspofungin, Mycafungin, and Anidulafungin.
Career Highlights
Throughout his career, Suto has worked with prominent pharmaceutical companies, including Teva Pharmaceutical Industries Ltd. His experience in the industry has allowed him to develop innovative solutions that enhance the efficacy of antifungal treatments.
Collaborations
Zsolt Tomas Suto has collaborated with several professionals in his field, including Vilmos Keri and Andrea Csorvasi. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Zsolt Tomas Suto is a distinguished inventor whose work in the purification of echinocandin-type compounds has made a significant impact on the pharmaceutical industry. His contributions continue to influence the development of effective antifungal therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile